TMS Co

TMS Co Inventory

The Inventory of TMS Co (4891.T) as of Nov 4, 2026 is 405,000.00 JPY. In the previous year, Inventory was 50.03 M JPY — a change of -99.19% (lower).

Inventory

405,000.00JPY

YoY

-99.19%

Last updated:

Inventory of TMS Co is 2025 405,000.00 JPY. Inventory of TMS Co was 2024 50.03 M JPY. It decreases by -99.19% lower compared to the previous year.

The TMS Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2021
42.15 M JPY
Jan 1, 2022
49.93 M JPY
Jan 1, 2023
223,000.00 JPY
Jan 1, 2024
50.03 M JPY
Jan 1, 2025
405,000.00 JPY
The TMS Co Inventory history
YEARInventoryYoY
405,000.00JPY-99.19%
50.03 MJPY+22,332.74%
223,000.00JPY-99.55%
49.93 MJPY+18.45%
42.15 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

TMS Co Stock analysis

What does TMS Co do? TMS Co., Ltd. generates revenue through the research and development of pharmaceutical products and medical devices, focusing on drug candidates targeting soluble epoxide hydrolase (sEH). The company develops sEH inhibitors for inflammatory diseases, with its lead candidate TMS-007 undergoing clinical development for acute cerebral infarction. TMS-007 combines anti-inflammatory and thrombolytic effects by inhibiting sEH and acting on plasminogen. The follow-on product TMS-008 is in pre-clinical studies for various inflammatory diseases. The company collaborates with academia and research institutions for R&D results, leveraging external research to advance its pipeline. TMS Co., Ltd. targets the pharmaceutical market for inflammatory disease treatments, focusing on drug candidates with dual mechanisms of action. Its primary customers are pharmaceutical companies and research institutions seeking innovative therapeutic solutions. The company's pipeline includes TMS-007 for acute cerebral infarction and TMS-008 for broader inflammatory conditions, positioning itself in the biopharmaceutical segment. The firm's revenue model relies on advancing its pipeline through clinical and pre-clinical stages, with potential partnerships for further development and commercialization. TMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TMS Co stock

Inventory of TMS Co is 405,000.00 JPY in 2025.

Inventory of TMS Co changed from 50.03 M JPY to 405,000.00 JPY, representing a -99.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory TMS Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's TMS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — TMS Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — TMS Co